These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15548526)

  • 61. An abortive ligand-induced activation of CCR1-mediated downstream signaling event and a deficiency of CCR5 expression are associated with the hyporesponsiveness of human naive CD4+ T cells to CCL3 and CCL5.
    Sato K; Kawasaki H; Morimoto C; Yamashima N; Matsuyama T
    J Immunol; 2002 Jun; 168(12):6263-72. PubMed ID: 12055240
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In silico study of 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl) ethanones derivatives as CCR1 antagonist: homology modeling, docking and 3D-QSAR approach.
    Balasubramanian PK; Balupuri A; Kothandan G; Cho SJ
    Bioorg Med Chem Lett; 2014 Feb; 24(3):928-33. PubMed ID: 24424131
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
    Duchesnes CE; Murphy PM; Williams TJ; Pease JE
    Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket.
    Boucard AA; Roy M; Beaulieu ME; Lavigne P; Escher E; Guillemette G; Leduc R
    J Biol Chem; 2003 Sep; 278(38):36628-36. PubMed ID: 12842881
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alanine scanning mutagenesis of CCR3 reveals that the three intracellular loops are essential for functional receptor expression.
    Auger GA; Pease JE; Shen X; Xanthou G; Barker MD
    Eur J Immunol; 2002 Apr; 32(4):1052-8. PubMed ID: 11920572
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Involvement of CC Chemokine Receptor 1 and CCL3 in Acute and Chronic Inflammatory Pain in Mice.
    Llorián-Salvador M; González-Rodríguez S; Lastra A; Fernández-García MT; Hidalgo A; Menéndez L; Baamonde A
    Basic Clin Pharmacol Toxicol; 2016 Jul; 119(1):32-40. PubMed ID: 26663750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells.
    Pevida M; Lastra A; Meana Á; Hidalgo A; Baamonde A; Menéndez L
    Neuroscience; 2014 Feb; 259():113-25. PubMed ID: 24316469
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1.
    Sanchez J; E Huma Z; Lane JR; Liu X; Bridgford JL; Payne RJ; Canals M; Stone MJ
    J Biol Chem; 2019 Mar; 294(10):3464-3475. PubMed ID: 30567735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
    Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
    Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2.
    Hata AN; Lybrand TP; Breyer RM
    J Biol Chem; 2005 Sep; 280(37):32442-51. PubMed ID: 16030019
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elucidation of the CCR1- and CCR5-binding modes of MIP-1α by application of an NMR spectra reconstruction method to the transferred cross-saturation experiments.
    Yoshiura C; Ueda T; Kofuku Y; Matsumoto M; Okude J; Kondo K; Shiraishi Y; Shimada I
    J Biomol NMR; 2015 Dec; 63(4):333-340. PubMed ID: 26472202
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A molecular switch of chemokine receptor selectivity. Chemical modification of the interleukin-8 Leu25 --> Cys mutant.
    Lusti-Narasimhan M; Chollet A; Power CA; Allet B; Proudfoot AE; Wells TN
    J Biol Chem; 1996 Feb; 271(6):3148-53. PubMed ID: 8621714
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts.
    Lean JM; Murphy C; Fuller K; Chambers TJ
    J Cell Biochem; 2002; 87(4):386-93. PubMed ID: 12397598
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Functional expression and characterization of macaque C-C chemokine receptor 3 (CCR3) and generation of potent antagonistic anti-macaque CCR3 monoclonal antibodies.
    Zhang L; Soares MP; Guan Y; Matheravidathu S; Wnek R; Johnson KE; Meisher A; Iliff SA; Mudgett JS; Springer MS; Daugherty BL
    J Biol Chem; 2002 Sep; 277(37):33799-810. PubMed ID: 12101185
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice.
    Morteau O; Castagliuolo I; Mykoniatis A; Zacks J; Wlk M; Lu B; Pothoulakis C; Gerard NP; Gerard C
    Gastroenterology; 2002 Mar; 122(3):725-33. PubMed ID: 11875005
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells.
    Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J
    Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular cloning and characterization of a cDNA, CHEMR1, encoding a chemokine receptor with a homology to the human C-C chemokine receptor, CCR-4.
    Youn BS; Kim SH; Lyu MS; Kozak CA; Taub DD; Kwon BS
    Blood; 1997 Jun; 89(12):4448-60. PubMed ID: 9192769
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays.
    Gilchrist A; Gauntner TD; Fazzini A; Alley KM; Pyen DS; Ahn J; Ha SJ; Willett A; Sansom SE; Yarfi JL; Bachovchin KA; Mazzoni MR; Merritt JR
    Br J Pharmacol; 2014 Nov; 171(22):5127-38. PubMed ID: 24990525
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
    Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
    Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors.
    Rose PM; Krystek SR; Patel PS; Liu EC; Lynch JS; Lach DA; Fisher SM; Webb ML
    FEBS Lett; 1995 Mar; 361(2-3):243-9. PubMed ID: 7698331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.